SRP6291
IFN-ω human
recombinant, expressed in HEK 293 cells, ≥93% (SDS-PAGE)
Manufacturer: Sigma Aldrich
Synonym(S): IFI, IFNG
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 μG | SRP6291-10-μG | In Stock | ₹ 30,547.20 |
SRP6291 - 10 μG
In Stock
Quantity
1
Base Price: ₹ 30,547.20
GST (18%): ₹ 5,498.496
Total Price: ₹ 36,045.696
biological source
human
recombinant
expressed in HEK 293 cells
Assay
≥93% (SDS-PAGE)
form
lyophilized powder
mol wt
calculated mol wt 16.8 kDa (no tag)observed mol wt 25.0 kDa (DTT-reduced. Protein migrates due to glycosylation. Gln 24 is the predicted N-terminus.)
packaging
pkg of 10 μg
impurities
<1 EU/μg endotoxin (LAL test)
UniProt accession no.
P01579
shipped in
wet ice
storage temp.
−20°C
Description
- General description: Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFN gamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression.
- Physical form: Lyophilized from 0.22 μm filtered solution in 20 mM Tris, 100 mM NaCl, pH 8.0. Generally 5-8% Mannitol or trehalose is added as a protectant before lyophilization.
- Reconstitution: Centrifuge the vial prior to opening. Reconstitute in sterile deionized water to a concentration of 100 μg/mL. Do not vortex. This solution can be stored at 2-8°C for up to 1 month. For extended storage, it is recommended to store at -20°C.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
recombinant: expressed in HEK 293 cells
Assay: ≥93% (SDS-PAGE)
form: lyophilized powder
mol wt: calculated mol wt 16.8 kDa (no tag)observed mol wt 25.0 kDa (DTT-reduced. Protein migrates due to glycosylation. Gln 24 is the predicted N-terminus.)
packaging: pkg of 10 μg
impurities: <1 EU/μg endotoxin (LAL test)
UniProt accession no.: P01579
shipped in: wet ice
storage temp.: −20°C
biological source:
human
recombinant:
expressed in HEK 293 cells
Assay:
≥93% (SDS-PAGE)
form:
lyophilized powder
mol wt:
calculated mol wt 16.8 kDa (no tag)observed mol wt 25.0 kDa (DTT-reduced. Protein migrates due to glycosylation. Gln 24 is the predicted N-terminus.)
packaging:
pkg of 10 μg
impurities:
<1 EU/μg endotoxin (LAL test)
UniProt accession no.:
P01579
shipped in:
wet ice
storage temp.:
−20°C
biological source: human
recombinant: expressed in HEK 293 cells
Assay: ≥95% (SDS-PAGE)
form: lyophilized powder
mol wt: calculated mol wt 17 kDa (no tag)observed mol wt 19 kDa (DTT-reduced. Protein migrates due to glycosylation. Asp26 is the predicted N-terminus.)observed mol wt 22 kDaobserved mol wt 26 kDa
packaging: pkg of 10 μg
impurities: <1 EU/μg endotoxin (LAL test)
UniProt accession no.: P13232
shipped in: wet ice
storage temp.: −20°C
biological source:
human
recombinant:
expressed in HEK 293 cells
Assay:
≥95% (SDS-PAGE)
form:
lyophilized powder
mol wt:
calculated mol wt 17 kDa (no tag)observed mol wt 19 kDa (DTT-reduced. Protein migrates due to glycosylation. Asp26 is the predicted N-terminus.)observed mol wt 22 kDaobserved mol wt 26 kDa
packaging:
pkg of 10 μg
impurities:
<1 EU/μg endotoxin (LAL test)
UniProt accession no.:
P13232
shipped in:
wet ice
storage temp.:
−20°C
biological source: mouse
recombinant: expressed in HEK 293 cells
Assay: ≥95% (SDS-PAGE)
form: lyophilized
mol wt: calculated mol wt 19.3 kDa (no tag)observed mol wt 23-25 kDa (DTT-reduced. Protein migrates due to glycosylation. Ala 27 is the predicted N-terminal.)
packaging: pkg of 10 μg
impurities: __
UniProt accession no.: Q00731
shipped in: wet ice
storage temp.: −20°C
biological source:
mouse
recombinant:
expressed in HEK 293 cells
Assay:
≥95% (SDS-PAGE)
form:
lyophilized
mol wt:
calculated mol wt 19.3 kDa (no tag)observed mol wt 23-25 kDa (DTT-reduced. Protein migrates due to glycosylation. Ala 27 is the predicted N-terminal.)
packaging:
pkg of 10 μg
impurities:
__
UniProt accession no.:
Q00731
shipped in:
wet ice
storage temp.:
−20°C
biological source: human
recombinant: expressed in HEK 293 cells
Assay: ≥95% (SDS-PAGE)
form: lyophilized
mol wt: calculated mol wt 76 kDaobserved mol wt 74 kDa by SDS-PAGE (DTT-reduced.)
packaging: pkg of 100 μgpkg of 20 μg
impurities: <1 EU/μg endotoxin (LAL test)
UniProt accession no.: P02787
shipped in: wet ice
storage temp.: __
biological source:
human
recombinant:
expressed in HEK 293 cells
Assay:
≥95% (SDS-PAGE)
form:
lyophilized
mol wt:
calculated mol wt 76 kDaobserved mol wt 74 kDa by SDS-PAGE (DTT-reduced.)
packaging:
pkg of 100 μgpkg of 20 μg
impurities:
<1 EU/μg endotoxin (LAL test)
UniProt accession no.:
P02787
shipped in:
wet ice
storage temp.:
__